share_log

Evercore ISI Group Maintains Outperform on Cabaletta Bio, Lowers Price Target to $15

Evercore ISI Group Maintains Outperform on Cabaletta Bio, Lowers Price Target to $15

Evercore ISI 集团继续维持 Cabaletta Bio 的跑赢大盘评级,并将目标股价调降至15美元。
Benzinga ·  08/12 09:57  · 评级/大行评级

Evercore ISI Group analyst Gavin Clark-Gartner maintains Cabaletta Bio (NASDAQ:CABA) with a Outperform and lowers the price target from $25 to $15.

Evercore ISI集团分析师Gavin Clark-Gartner认为,Cabaletta Bio (纳斯达克股票代码:CABA) 的表现优异,将目标价从25美元下调至15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发